We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Dose-Guided Radiation Therapy System

By HospiMedica staff writers
Posted on 18 Oct 2004
A new integrated dose-guided radiation therapy (DGRT) system was introduced at the annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Atlanta (GA, USA) in October 2004.

The Artiste linear accelerator, developed by Siemens Medical Solutions (Erlangen, Germany), utilizes Siemens' In-Line technology, and provides advanced treatment capabilities beyond image-guided radiation therapy (IGRT). More...
Where current IGRT approaches focus on accurate delivery based upon tumor position, DRGT introduces the consideration of anatomy and dosimetric changes into the treatment protocol. DRGT relies upon information about the tumor shape and treatment dose to adapt the treatment.

"With Artiste, we see a way to demonstrate that it is not only possible, but necessary, to integrate both kilovoltage [kV] and megavoltage [MV] cone beam imaging into a linear accelerator. We are ‘closing the loop,'--the feedback loop--to provide our customers with treatment tools that will allow them to provide true adaptive radiation therapy. And to benefit both the clinician and the patient, we are able to do this without surrounding the patient,” stated Ajit Singh, president of Siemens Oncology Care Systems Group.

This advanced system for the delivery of adaptive radiation therapy (ART) will provide both kV and MV imaging capabilities by providing a separate radiation source and imaging panel for each energy range. Each energy range is then used to provide the images necessary for DGRT, and can become the basis of distinct imaging and treatment capabilities. The arrangement of the sources and imaging panels are 180o (in-line) from one another, which allows the system to be unique in the intent to provide the capability to image both the patient and the treatment simultaneously. In addition, this provides synchronized image and dose monitoring, quality cone beam information correlated with the treatment plan, and both entrance and exit treatment ports.




Related Links:
Siemens Medical Solutions

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Electrode Solution and Skin Prep
Signaspray
Medical Monitor
VITALMAX 4100SL
Autoclave
Advance
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.